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EDITORIAL
Beyond cyclooxygenase
Real estate agents are known to regale prospective versus COX-2, thereby limiting the end product forma-
buyers with the maxim “Location! Location! Location!” tion and the physiologic consequences of PGH2 forma-
The same mantra should be kept in mind when consider- tion.
ing the action of prostanoids. As opposed to circulating Whether a cell synthesizes thromboxane A2, PGE2, or
hormones, such as insulin and vasopressin, which act upon prostacyclin depends almost entirely on the accessibility
tissues distant from their site of production, prostanoids of the specific prostanoid synthase that metabolizes PGH2.
are rapidly metabolically degraded, limiting their effects Thus, platelets express abundant thromboxane synthase
to the immediate vicinity of their synthetic site. This and primarily produce thromboxane A2 [8–10]. Similarly,
circumstance dictates that the entire enzymatic machin- smooth muscle and endothelial cells express abundant
ery required for production of a specific prostanoid be prostacyclin synthase, corresponding to their high rate
localized at its site of action and, furthermore, that the of prostacylin synthesis [11]. What, then, are the main
receptor(s) mediating the action of this prostanoid be prostanoid synthases localized together with COX-1 and
locally available. COX-2 in the kidney?
Prostanoids are composed of a diverse group of un- In this issue of Kidney International, Vitzhum et al
saturated, oxygenated fatty acids, derived from the en- further define the distribution of mRNAs for prostanoid
zymatic metabolism of arachidonic acid, by cyclooxy- synthases along the nephron [12]. These studies used re-
genase-1 (COX-1) or cyclooxygenase 2 (COX-2). Both verse transcription-polymerase chain reaction (RT-PCR)
cyclooxgenase isoforms convert arachidonate to the same on microdissected nephron segments to confirm the pre-
product, the bioactive but unstable prostanoid precursor, viously described differential expression of COX-1 and
prostaglandin H2 (PGH2). Once formed, PGH2’s fate is COX-2 along the nephron. In addition, these investiga-
determined by further metabolic processing via a set tors described the expression pattern of the associated
of enzymatic synthases, yielding either prostaglandin E2 prostanoid synthases. In agreement with earlier studies
(PGE2), prostaglandin F2 (PGF2), prostaglandin D2 of Farman, Pradelles and Bonvalet [13], and more recent
(PGD2), thromboxane A2, or prostacyclin. The effects of studies of microsomal PGE synthase expression in mouse
each these prostanoids is, in turn, mediated by a family kidney [14], these investigators found the highest expres-
of G protein-coupled transmembrane receptors that pos- sion of microsomal PGE synthase in the collecting duct.
sess both ligand and signaling specificity. Just because an enzyme possesses the capacity to me-
It is now well established that COX-1 and COX-2 tabolize PGH2 to a specific prostanoid in vitro, does not
are differentially expressed along the nephron. Whereas mean that this is its role in the intact organism. Indeed,
COX-1 is highly expressed in the collecting duct [1, 2], the existence of another enzyme catalyzing PGE synthe-
COX-2 expression is restricted to the cortical thick as- sis has been reported [15]. Thus, it is reassuring that dis-
cending limb, specifically in cells associated with the mac- ruption of the gene for this microsomal PGE synthase
ula densa [2–4]. COX-2 is also highly expressed in medul- completely blocked lipopolysaccharide stimulated PGE2
lary interstitial cells [2, 5]. The significance of this distinct production in mice [16]. Taken together, these studies
isoform localization appears to be more than a mere define microsomal PGE synthase as an enzyme down-
curiosity since selective COX-2 inhibition accentuates stream of renal COX-1 and possibly responsible for PGE2
the pressor effects of angiotensin II, whereas COX-1 synthesis by the collecting duct. Importantly, the collect-
inhibition reduces its pressor effect [2]. One possible ing duct also expresses abundant E prostanoid receptors,
explanation for these observations is that COX-1 activ- including EP1, EP3, and EP4 receptors through which
ity primarily yields a pressor such as thromboxane A2, PGE2 presumably exerts its natriuretic and diruetic ef-
whereas COX-2 mediates the production of a vaso- fects [17]. An unanswered question is whether PGE2 de-
depressor like prostacyclin [6, 7]. This implies that dis- rived from collecting duct COX-1 versus interstitial cell
tinct enzymatic machinery is co-expressed with COX-1 COX-2 have differential access to distinct EP receptor
subtypes along the collecting duct.
Prostacyclin synthase and thromboxane synthase wereKey words: oxygenated fatty acids, reverse transcription-polymerase
also detected in the kidney by RT-PCR. Since prostacylinchain reaction, prostanoid synthases, thick ascending limb, angiotensin
II, prostaglandins. synthase was not detected in any of the nephron seg-
ments studied, Vitzthum et al infer that it must be ex- 2002 by the International Society of Nephrology
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